Related Experiment Video
Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
Signe Schmidt1, Dimitri Boiroux, Anne Katrine Duun-Henriksen
1Department of Endocrinology, Copenhagen University Hospital Hvidovre, Kettegård Alle 30, 2650 Hvidovre, Denmark. signe.schmidt@regionh.dk.
A new model predictive control (MPC) algorithm for closed-loop (CL) glucose control in type 1 diabetes mellitus (T1DM) demonstrated safe and effective overnight glucose management. This advanced system improved time in range compared to open-loop control.
Area of Science:
- Biomedical Engineering
- Control Systems
- Endocrinology
Background:
- Type 1 diabetes mellitus (T1DM) management requires precise glucose control.
- A novel model predictive control (MPC) algorithm was developed for closed-loop (CL) glucose regulation.
- The algorithm utilizes a linear second-order deterministic-stochastic model with patient-specific parameters.
Purpose of the Study:
- To present the results of the first clinical feasibility test of the developed MPC algorithm.
- To evaluate the safety and efficacy of the MPC algorithm for overnight glucose control in T1DM patients.
Main Methods:
- Two randomized crossover studies were conducted.
- Study 1 compared CL control with open-loop (OL) control.
- Study 2 compared CL control initiated in euglycemic (CL-Eu) versus hyperglycemic (CL-Hyper) ranges.
Main Results:
- Hypoglycemic events were reduced with CL control compared to OL control in Study 1.
- Median time in the target glucose range (70-144 mg/dl) was significantly higher with CL control (80.8%) versus OL control (67.9%).
- Study 2 showed better glucose control in CL-Eu compared to CL-Hyper, with fewer hypoglycemic events.
Conclusions:
- The novel MPC algorithm provides safe and effective overnight glucose control for T1DM patients.
- The algorithm demonstrates efficacy even when CL control is initiated during hyperglycemia.
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

